Merck & Co. Retained Earnings decreased by 8.7% to $66.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from $66.10B to $66.72B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 9.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.78B | $51.69B | $53.70B | $56.25B | $58.44B | $59.93B | $61.08B | $62.04B | $54.20B | $57.08B | $53.90B | $56.70B | $60.19B | $61.38B | $63.07B | $66.10B | $68.48B | $72.23B | $73.08B | $66.72B |
| QoQ Change | — | +6.0% | +3.9% | +4.8% | +3.9% | +2.6% | +1.9% | +1.6% | -12.6% | +5.3% | -5.6% | +5.2% | +6.2% | +2.0% | +2.7% | +4.8% | +3.6% | +5.5% | +1.2% | -8.7% |
| YoY Change | — | — | — | — | +19.8% | +15.9% | +13.8% | +10.3% | -7.3% | -4.7% | -11.8% | -8.6% | +11.1% | +7.5% | +17.0% | +16.6% | +13.8% | +17.7% | +15.9% | +0.9% |